DONATE

Bridging Science and Investments for Improved Outcomes

Proof-of-concept funding here
Evergreen & mission-first
ANRF scientific partner
Immune Boost Capital (IBC) is the philanthropic venture subsidiary of the Arthritis National Research Foundation. The mission of IBC is to invest in early promising autoimmune diagnostics and therapeutics, recycling 100% of returns to fuel future innovation.
CONTACT IBC
OUR INVESTMENT APPROACH

Bridging Science with Investments in early stage translational opportunities for Improved Outcomes

Strategic funding, scientific partnership, and recycled returns driving the future of diagnostics and therapeutics.

Relationship with the Arthritis National Research Foundation

ANRF is a financial and scientific partner. IBC remains operationally independent, guided by experienced investors, scientists, and healthcare leaders.

Translational Impact

Enabling founders and investigators to generate the data needed to attract follow-on venture and strategic investment.

Autoimmune Focus

IBC will consider investments across the full spectrum of autoimmune conditions.

Recycled Returns

IBC is an evergreen fund which will reinvest all proceeds from successful investments in future investments. Contributions to IBC will provide immediate donor tax benefits as well as the potential to have a long-term impact on new therapeutic options for patients.